"description","label","name","identifier","uuid:ID","instanceType","text","id"
"The study age criterion","","Age Criteria","1","5fa24a41-2a20-4d64-bb2b-147654d1d6f2","ELIGIBILITY_CRITERIA","Subjects shall be between [min_age] and [max_age]","EligibilityCriteria_1"
"The study population criterion","","Pop Criteria","2","01b99067-f6f0-4a95-86fd-3ce782237dc3","ELIGIBILITY_CRITERIA","[StudyPopulation] as defined by the NINCDS and the ADRDA guidelines (Attachment LZZT.7)","EligibilityCriteria_2"
"The study diagnosis criterion","","Diag Criteria","3","896b2778-00ba-451b-b6c9-3dc1b9ce19cc","ELIGIBILITY_CRITERIA","[Activity1] score of 10 to 23","EligibilityCriteria_3"
"The previous xanomeline TTS criterion","","Previous Criteria","9","d7375521-a554-4b0e-85a6-00fb663cfc4c","ELIGIBILITY_CRITERIA","Persons who have previously completed or withdrawn from this study or any other study investigating xanomeline TTS or the oral formulation of xanomeline.","EligibilityCriteria_4"
